Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02991690 · ClinicalTrials.gov registry record · NA

Systemic Hypothermia in Acute Cervical Spinal Cord Injury

A NA study of Spinal Cord Injury, Acute, sponsored by University of Miami.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
7
Study locations

NCT02991690 is a NA study of Spinal Cord Injury, Acute that is actively recruiting participants, run by University of Miami. The registered enrollment target is 120 participants. The trial reports 7 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02991690, a NA study of Spinal Cord Injury, Acute, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
7
Study locations

Study Summary

This study is a prospective multi-center trial designed to determine the safety profile and efficacy of modest (33ºC) intravascular hypothermia following acute cervical (C1 to C8) Spinal Cord Injury (SCI).

Conditions Studied

Interventions

  • OTHER Hypothermia

Study Locations (7)

Arizona

  • HonorHealth Research Institute with Barrow Brain and Spine - Phoenix

Florida

  • Jackson Memorial Hospital - Miami

Georgia

  • Emory University School of Medicine - Atlanta

Indiana

  • Indiana University School of Medicine - Indianapolis

Maryland

  • University of Maryland School of Medicine - Baltimore

Pennsylvania

  • Thomas Jefferson University - Philadelphia

South Carolina

  • Prisma Health - University of South Carolina - Columbia

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2017-08-04
Est. Completion 2026-09
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT02991690

The ClinicalTrials.gov registry entry for NCT02991690 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Spinal Cord Injury, Acute appearing as the primary indexed condition, and to 1 intervention - of which Hypothermia is the first listed.

NCT02991690 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Arizona, Florida, Georgia.

Frequently Asked Questions

What is clinical trial NCT02991690 about?

NCT02991690 is a clinical study titled "Systemic Hypothermia in Acute Cervical Spinal Cord Injury". This study is a prospective multi-center trial designed to determine the safety profile and efficacy of modest (33ºC) intravascular hypothermia following acute cervical (C1 to C8) Spinal Cord Injury (SCI).

What is the current status of trial NCT02991690?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2017-08-04. Estimated completion is 2026-09.

What conditions does trial NCT02991690 study?

This clinical trial studies the following conditions: Spinal Cord Injury, Acute.

What interventions are being tested in trial NCT02991690?

The interventions under investigation include: Hypothermia (OTHER).

Who is sponsoring clinical trial NCT02991690?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02991690 being conducted?

This trial has 7 study locations across Arizona, Florida, Georgia, Indiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injury, Acute

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.